Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: R etrospective data for 10 256 individuals from the U nited K ingdom and G ermany

Author:

Khunti Kamlesh1ORCID,Godec Thomas R.2,Medina Jesús3,Garcia‐Alvarez Laura4,Hiller Josh5,Gomes Marilia B.6,Cid‐Ruzafa Javier7,Charbonnel Bernard8,Fenici Peter9,Hammar Niklas1011,Hashigami Kiyoshi12,Kosiborod Mikhail1314,Nicolucci Antonio15,Shestakova Marina V.1617,Ji Linong18ORCID,Pocock Stuart2

Affiliation:

1. University of Leicester Leicester UK

2. London School of Hygiene and Tropical Medicine London UK

3. AstraZeneca Madrid Spain

4. QuintilesIMS Health Barcelona Spain

5. QuintilesIMS Health London UK

6. Rio de Janeiro State University Rio de Janeiro Brazil

7. Evidera Barcelona Spain

8. University of Nantes Nantes France

9. AstraZeneca Cambridge UK

10. AstraZeneca Gothenburg Mölndal Sweden

11. Institute of Environmental Medicine, Karolinska Institutet Stockholm Sweden

12. AstraZeneca Tokyo Japan

13. Saint Luke's Mid America Heart Institute Kansas City Missouri

14. University of Missouri Kansas City Missouri

15. Center for Outcomes Research and Clinical Epidemiology Pescara Italy

16. Endocrinology Research Centre, Diabetes Institute Moscow Russian Federation

17. I. M. Sechenov First Moscow State Medical University Moscow Russian Federation

18. Peking University People's Hospital Beijing China

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3